Cao Bo, Zhou Xin, Ma Jiaojiao, Zhou Wei, Yang Wanli, Fan Daiming, Hong Liu
The First Brigade of Student, Fourth Military Medical University, Xi'an, Shaanxi Province, China.
State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
Dig Dis Sci. 2017 Jun;62(6):1426-1438. doi: 10.1007/s10620-017-4567-1. Epub 2017 Apr 8.
Inflammatory bowel diseases (IBD), mainly including Crohn's disease and ulcerative colitis, are characterized by chronic inflammation of the gastrointestinal tract. Despite improvements in detection, drug treatment and surgery, the pathogenesis of IBD has not been clarified. A number of miRNAs have been found to be involved in the initiation, development and progression of IBD, and they may have the potential to be used as biomarkers and therapeutic targets. Here, we have summarized the recent advances about the roles of miRNAs in IBD and analyzed the contribution of miRNAs to general diagnosis, differential diagnosis and activity judgment of IBD. Furthermore, we have also elaborated the promising role of miRNAs in IBD-related cancer prevention and prognosis prediction.
炎症性肠病(IBD)主要包括克罗恩病和溃疡性结肠炎,其特征为胃肠道的慢性炎症。尽管在检测、药物治疗和手术方面有所进展,但IBD的发病机制尚未阐明。已发现多种微小RNA(miRNA)参与IBD的起始、发展和进程,它们可能有潜力用作生物标志物和治疗靶点。在此,我们总结了miRNA在IBD中作用的最新进展,并分析了miRNA对IBD的一般诊断、鉴别诊断和活动度判断的贡献。此外,我们还阐述了miRNA在IBD相关癌症预防和预后预测中的潜在作用。
Dig Dis Sci. 2017-6
World J Gastroenterol. 2024-4-28
World J Gastroenterol. 2016-2-21
Int J Biol Sci. 2021
Curr Opin Gastroenterol. 2016-7
BMC Immunol. 2015-2-10
Med Sci (Paris). 2013-12
Int J Mol Sci. 2020-10-24
J Cell Physiol. 2018-11-11
Saudi J Gastroenterol. 2025-7-1
Clin Exp Med. 2024-9-11
Therap Adv Gastroenterol. 2024-5-9
Immun Inflamm Dis. 2023-12
Front Pediatr. 2022-11-28
BioTech (Basel). 2022-4-20
Biomedicines. 2022-5-30
J Transl Med. 2016-6-8
Int J Mol Sci. 2016-5-11
Intest Res. 2016-4
Int J Mol Sci. 2016-4-19